Aerovate Therapeutics, Inc. Current Ratio in % from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aerovate Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2025.
  • Aerovate Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 979 %, a 38% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Aerovate Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 979 +270 +38% Sep 30, 2025
Q2 2025 994 +261 +35.5% Jun 30, 2025
Q1 2025 835 -11.7 -1.38% Mar 31, 2025
Q4 2024 682 -268 -28.2% Dec 31, 2024
Q3 2024 709 -459 -39.3% Sep 30, 2024
Q2 2024 733 -662 -47.4% Jun 30, 2024
Q1 2024 846 -997 -54.1% Mar 31, 2024
Q4 2023 950 -1.54K -61.8% Dec 31, 2023
Q3 2023 1.17K -2.25K -65.8% Sep 30, 2023
Q2 2023 1.39K -3.17K -69.4% Jun 30, 2023
Q1 2023 1.84K -1.97K -51.7% Mar 31, 2023
Q4 2022 2.49K Dec 31, 2022
Q3 2022 3.41K Sep 30, 2022
Q2 2022 4.56K Jun 30, 2022
Q1 2022 3.82K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.